The QIAstat-Dx Meningitis/Encephalitis Panel is a rapid molecular diagnostic test designed to detect multiple bacterial, viral, and fungal pathogens associated with meningitis and encephalitis from a single cerebrospinal fluid sample. Using advanced multiplex PCR technology, the test helps quickly identify infectious causes of inflammation affecting the brain and surrounding membranes. Its purpose is to support early diagnosis, enable timely treatment decisions, and improve patient management in potentially life-threatening neurological infections.
The panel detects selected bacterial, viral, and fungal pathogens commonly linked to meningitis and encephalitis infections.
Individuals with symptoms such as fever, headache, neck stiffness, confusion, seizures, or neurological symptoms may require this test.
Certainly, the panel identifies several viruses commonly associated with meningitis and encephalitis infections affecting the central nervous system.
Yes, the panel includes detection of selected fungal pathogens associated with meningitis or encephalitis in specific clinical situations.
Certainly, the test may be used in both children and adults when meningitis or encephalitis is clinically suspected.
No, the test identifies specific pathogens included in the panel and may not detect every possible neurological infection.
Rapid diagnosis enables early treatment, reduces complications, improves patient outcomes, and supports timely infection control measures.
...
Didn't recieved OTP Yet? Resend OTP